dose response function fitting in originpro 9.7 Search Results


90
GraphPad Software Inc graphpad prism 5.0
Graphpad Prism 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism 5.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism 5.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc sigmoidal dose response curve fit
Sigmoidal Dose Response Curve Fit, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sigmoidal dose response curve fit/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
sigmoidal dose response curve fit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism version 5.04 software
Prism Version 5.04 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism version 5.04 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism version 5.04 software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti mif polyclonal antibody
A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or <t>anti-MIF</t> <t>polyclonal</t> antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.
Anti Mif Polyclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mif polyclonal antibody/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
anti mif polyclonal antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
GraphPad Software Inc dose-response—inhibition curve software
A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or <t>anti-MIF</t> <t>polyclonal</t> antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.
Dose Response—Inhibition Curve Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dose-response—inhibition curve software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
dose-response—inhibition curve software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc variable slope dose-response curve (prism)
A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or <t>anti-MIF</t> <t>polyclonal</t> antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.
Variable Slope Dose Response Curve (Prism), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/variable slope dose-response curve (prism)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
variable slope dose-response curve (prism) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc dose-response-ec50 equation
A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or <t>anti-MIF</t> <t>polyclonal</t> antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.
Dose Response Ec50 Equation, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dose-response-ec50 equation/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
dose-response-ec50 equation - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc three-parameter dose–response curve graphpad prism
A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or <t>anti-MIF</t> <t>polyclonal</t> antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.
Three Parameter Dose–Response Curve Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/three-parameter dose–response curve graphpad prism/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
three-parameter dose–response curve graphpad prism - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism 9.0
Anti-SARS-CoV-2 activity of dairy products. (A) Dose-response curves for dairy products. Data shown are the mean ± SEM of 10-point, 2-fold dilution series (n = 3 replicates per condition). Curve fitting was performed using GraphPad Prism 9.0 using a semi-log 4-parameter variable slope model. (B) Representative images for efficacious samples (e.g., 11-20-014-04) and the viral control. Cell nuclei are shown in cyan; viral nucleocapsid protein is shown in magenta. Images shown were taken on a Yokogawa CV8000 high-content microscope at 20× magnification and colored using ImageJ (National Institutes of Health).
Graphpad Prism 9.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism 9.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism 9.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear curve-fitting program (sigmoidal dose response)
Anti-SARS-CoV-2 activity of dairy products. (A) Dose-response curves for dairy products. Data shown are the mean ± SEM of 10-point, 2-fold dilution series (n = 3 replicates per condition). Curve fitting was performed using GraphPad Prism 9.0 using a semi-log 4-parameter variable slope model. (B) Representative images for efficacious samples (e.g., 11-20-014-04) and the viral control. Cell nuclei are shown in cyan; viral nucleocapsid protein is shown in magenta. Images shown were taken on a Yokogawa CV8000 high-content microscope at 20× magnification and colored using ImageJ (National Institutes of Health).
Nonlinear Curve Fitting Program (Sigmoidal Dose Response), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear curve-fitting program (sigmoidal dose response)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear curve-fitting program (sigmoidal dose response) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc computer-assisted curve fitting sigmoidal dose-response graphpad prism 1.0
Anti-SARS-CoV-2 activity of dairy products. (A) Dose-response curves for dairy products. Data shown are the mean ± SEM of 10-point, 2-fold dilution series (n = 3 replicates per condition). Curve fitting was performed using GraphPad Prism 9.0 using a semi-log 4-parameter variable slope model. (B) Representative images for efficacious samples (e.g., 11-20-014-04) and the viral control. Cell nuclei are shown in cyan; viral nucleocapsid protein is shown in magenta. Images shown were taken on a Yokogawa CV8000 high-content microscope at 20× magnification and colored using ImageJ (National Institutes of Health).
Computer Assisted Curve Fitting Sigmoidal Dose Response Graphpad Prism 1.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computer-assisted curve fitting sigmoidal dose-response graphpad prism 1.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
computer-assisted curve fitting sigmoidal dose-response graphpad prism 1.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc logistic dose-response curve
Anti-SARS-CoV-2 activity of dairy products. (A) Dose-response curves for dairy products. Data shown are the mean ± SEM of 10-point, 2-fold dilution series (n = 3 replicates per condition). Curve fitting was performed using GraphPad Prism 9.0 using a semi-log 4-parameter variable slope model. (B) Representative images for efficacious samples (e.g., 11-20-014-04) and the viral control. Cell nuclei are shown in cyan; viral nucleocapsid protein is shown in magenta. Images shown were taken on a Yokogawa CV8000 high-content microscope at 20× magnification and colored using ImageJ (National Institutes of Health).
Logistic Dose Response Curve, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/logistic dose-response curve/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
logistic dose-response curve - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or anti-MIF polyclonal antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.

Journal: PLoS ONE

Article Title: Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells

doi: 10.1371/journal.pone.0076206

Figure Lengend Snippet: A . Representative images showing a temporal changes of macrophages (CD68+ cells, purple colour) by immunohistochemical staining in mice treated with isotype control IgG or anti-MIF polyclonal antibody (MIF Ab) post MI. Bar=100 μm. B , C . Grouped data showing that neutralizing MIF by anti-MIF Ab, i.p. given immediately after MI, significantly reduced density of macrophages ( B , CD68 positive cells) and leukocytes ( C , CD45+ cells) at 24 h, but had no effect on macrophage density at 7 days. n=3 for sham-operated groups (SH) and n=6-7 for each time point of MI groups. * P<0 . 05 vs. respective SH, † P<0.05 vs. respective 24 h MI, # P <0.05. D . Representative immunoblotting images for monocyte chemoattractant protein 1 (MCP-1) and CD74 in hearts from sham-operated or MI (24 h) mice treated with isotype control IgG or MIF Ab. E , F . Quantitative analysis of MCP-1 ( E ) and CD74 ( F ) expression. n=3/per sham group, n=5/per MI group. * P<0 . 05 vs. sham, # P<0.05 . G . Effects of anti-MIF Ab and isotype control IgG (CTL) treatment on healing parameters, i.e. size of residual necrotic myocardium and collagen content in the infarct area, and infarct wall thickness at 7 days post MI. n=4-6/group. H . Representative photos of ruptured hearts that occurred at 3-4 days after MI. Arrows indicate the rupture site around the border zone. I . Treatment with the MIF antagonist, COR100140, in the first 3 days post MI significantly reduced incidence of cardiac rupture. n=25 for untreated and 15 for treated groups.

Article Snippet: To investigate the effect of anti-MIF intervention on inflammatory responses, animals were treated with a single dose of anti-MIF polyclonal antibody (Santa Cruz, sc-20121) or isotype control rabbit IgG (Santa Cruz, sc-2027), at 5 mg/kg i.p. immediately after CAO.

Techniques: Immunohistochemical staining, Staining, Control, Western Blot, Expressing

Anti-SARS-CoV-2 activity of dairy products. (A) Dose-response curves for dairy products. Data shown are the mean ± SEM of 10-point, 2-fold dilution series (n = 3 replicates per condition). Curve fitting was performed using GraphPad Prism 9.0 using a semi-log 4-parameter variable slope model. (B) Representative images for efficacious samples (e.g., 11-20-014-04) and the viral control. Cell nuclei are shown in cyan; viral nucleocapsid protein is shown in magenta. Images shown were taken on a Yokogawa CV8000 high-content microscope at 20× magnification and colored using ImageJ (National Institutes of Health).

Journal: Journal of Dairy Science

Article Title: Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern

doi: 10.3168/jds.2021-21247

Figure Lengend Snippet: Anti-SARS-CoV-2 activity of dairy products. (A) Dose-response curves for dairy products. Data shown are the mean ± SEM of 10-point, 2-fold dilution series (n = 3 replicates per condition). Curve fitting was performed using GraphPad Prism 9.0 using a semi-log 4-parameter variable slope model. (B) Representative images for efficacious samples (e.g., 11-20-014-04) and the viral control. Cell nuclei are shown in cyan; viral nucleocapsid protein is shown in magenta. Images shown were taken on a Yokogawa CV8000 high-content microscope at 20× magnification and colored using ImageJ (National Institutes of Health).

Article Snippet: Dose-response curves for this data were fitted in GraphPad Prism 9.0 (GraphPad Software) using a semi-log 4-parameter variable slope model.

Techniques: Activity Assay, Microscopy